Literature DB >> 6142919

Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera.

Y Takasaki, D Fishwild, E M Tan.   

Abstract

A nuclear antigen associated with cell proliferation (proliferating cell nuclear antigen [PCNA]) and blast transformation is recognized by autoantibodies in the sera of some patients with systemic lupus erythematosus. Using this autoantibody as a reagent, PCNA was purified 120-fold by ammonium sulfate fractionation, DEAE chromatography, and Sephadex G200 gel filtration. The antigenicity of PCNA was sensitive to trypsin but resistant to ribonuclease and deoxyribonuclease, suggesting that the antigenic determinant resided in protein and not nucleic acids. PCNA was inactivated at 56 degrees C for 30 min. Isoelectrophoretic focusing showed that the pI was 4.8. Analysis of immunoprecipitates on polyacrylamide gels showed the presence of IgG heavy and light chains and a single polypeptide band of 33,000 mol wt. This polypeptide band was the reactive antigen in immunoblotting (Western transfer) assays.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6142919      PMCID: PMC2187268          DOI: 10.1084/jem.159.4.981

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis.

Authors:  N Kurata; E M Tan
Journal:  Arthritis Rheum       Date:  1976 May-Jun

2.  Autoantibody to a nuclear antigen in proliferating cells.

Authors:  K Miyachi; M J Fritzler; E M Tan
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Antinucleolar antibodies in human sera.

Authors:  J L Pinnas; J D Northway; E M Tan
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

5.  The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1969-01

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

8.  Changes in the synthesis of actin and other cell proteins after stimulation of serum-arrested cells.

Authors:  V G Riddle; R Dubrow; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

9.  Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation.

Authors:  R Bravo; S J Fey; J Bellatin; P M Larsen; J Arevalo; J E Celis
Journal:  Exp Cell Res       Date:  1981-12       Impact factor: 3.905

10.  Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus.

Authors:  M R Lerner; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

View more
  34 in total

1.  Presentation of autoantibody to proliferating cell nuclear antigen in patients with chronic hepatitis B and C virus infection.

Authors:  B S Tzang; T Y Chen; T C Hsu; Y C Liu; G J Tsay
Journal:  Ann Rheum Dis       Date:  1999-10       Impact factor: 19.103

2.  An inhibitor of the in vitro elongation reaction of simian virus 40 DNA replication is overcome by proliferating-cell nuclear antigen.

Authors:  S H Lee; Y Ishimi; M K Kenny; P Bullock; F B Dean; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

3.  Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions.

Authors:  Yuri Ozawa; Hiroyuki Kobori; Yuki Suzaki; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2006-06-27

4.  Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase.

Authors:  J E Celis; A Celis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Induction of proliferating cell nuclear antigen (PCNA)-immunoreactive cells in goldfish retina following intravitreal injection with 6-hydroxydopamine.

Authors:  K Negishi; W K Stell; T Teranishi; A Karkhanis; V Owusu-Yaw; Y Takasaki
Journal:  Cell Mol Neurobiol       Date:  1991-12       Impact factor: 5.046

6.  Repression of the Drosophila proliferating-cell nuclear antigen gene promoter by zerknüllt protein.

Authors:  M Yamaguchi; F Hirose; Y Nishida; A Matsukage
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

7.  Molecular characterisation and stage-specific expression of proliferating cell nuclear antigen (PCNA) from the malarial parasite, Plasmodium falciparum.

Authors:  B J Kilbey; I Fraser; S McAleese; M Goman; R G Ridley
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

8.  Long term prognosis of children born to lupus patients.

Authors:  A Murashima; T Fukazawa; M Hirashima; Y Takasaki; M Oonishi; S Niijima; Y Yamashiro; A Yamataka; T Miyano; H Hashimoto
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

9.  Kinetics and differentiation of somite cells forming the vertebral column: studies on human and chick embryos.

Authors:  J Wilting; H Kurz; B Brand-Saberi; G Steding; Y X Yang; H M Hasselhorn; H H Epperlein; B Christ
Journal:  Anat Embryol (Berl)       Date:  1994-12

10.  Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins.

Authors:  J M Almendral; D Huebsch; P A Blundell; H Macdonald-Bravo; R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.